10531-42-7 Usage
General Description
2-Bromo-1-(5-methyl-thiophen-2-yl)-ethanone is a chemical compound with the molecular formula C8H7BrOS. It is a brominated ketone derivative of thiophene, which is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and materials. 2-BROMO-1-(5-METHYL-THIOPHEN-2-YL)-ETHANONE is known for its aromatic and reactive properties, and it is often used as a key intermediate in the production of various organic molecules. Its structure consists of a bromine atom attached to a carbon atom, a ketone group, and a thiophene ring with a methyl group attached at the 5-position. Due to its potential use in the development of various important products, 2-Bromo-1-(5-methyl-thiophen-2-yl)-ethanone is of interest to researchers and chemists in the field of organic synthesis and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 10531-42-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,5,3 and 1 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 10531-42:
(7*1)+(6*0)+(5*5)+(4*3)+(3*1)+(2*4)+(1*2)=57
57 % 10 = 7
So 10531-42-7 is a valid CAS Registry Number.
10531-42-7Relevant articles and documents
Based on isoxazole substitution of benzamide derivatives and anti-prostate cancer drug applications
-
Paragraph 0065; 0073-0074, (2022/01/10)
The present invention discloses a class (I), formula (II) structure based on isoxazole substituted benzamide derivatives and antiprostate cancer drug applications, such isoxazole substituted benzamide derivatives, can effectively inhibit the activity of a
PIPERAZINE DERIVATIVES AND THE USE THEREOF AS MEDICAMENT
-
Page/Page column 50; 51, (2015/05/05)
The present inventions relate to substituted piperazine derivatives of general formula (I) and to the manufacture of said compounds, pharmaceutical compositions comprising a compound according to general formula (I), and the use of said compounds for the treatment of various medical conditions related to glycine transporter-1 (GlyT1).
